Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity.
Wallace DK, Hercinovic A, Freedman SF, Crouch ER, Bhatt AR, Hartnett ME, Yang MB, Rogers DL, Hutchinson AK, Good WV, Repka MX, Li Z, Beck RW, Kraker RT, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group.
Wallace DK, et al. Among authors: freedman sf.
J AAPOS. 2023 Feb;27(1):10.e1-10.e8. doi: 10.1016/j.jaapos.2022.11.020. Epub 2023 Jan 19.
J AAPOS. 2023.
PMID: 36681111
Free PMC article.